Valamehr Bahram
President and CEO at FATE
- Sold, on record
- $14.4M
- Dollars the filings state
- Form 4 sales
- 21
- Latest Aug 4, 2026
- Form 144 notices
- 6
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- FATEFATE THERAPEUTICS INCPresident and CEO
Sales by reason
0
Routine
14
Plan not stated
4
No plan
3
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Aug 4, 2026Unusual
Sold 6.9% of their holdings
$108k43,947 shares at $2.46
- Aug 4, 2026Notice
Filed a notice to sell 43,947 shares
$108k43,947 shares
- May 20, 2026Unusual
Sold 4.4% of their holdings
$54k28,946 shares at $1.88
- May 20, 2026Notice
Filed a notice to sell 28,946 shares
$54k28,946 shares
- Jan 9, 2026No plan
Sold 1.5% of their holdings
$6k5,190 shares at $1.07
- Jan 9, 2026Notice
Filed a notice to sell 5,190 shares
$6k5,190 shares
- Aug 4, 2025No plan
Sold 4.1% of their holdings
$15k14,466 shares at $1.06
- Aug 4, 2025Notice
Filed a notice to sell 14,466 shares
$15k14,466 shares
- Jan 10, 2025No plan
Sold 2.4% of their holdings
$13k8,705 shares at $1.54
- Jan 10, 2025Notice
Filed a notice to sell 8,705 shares
$13k8,705 shares
10 of 27
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Aug 5, 2026 | FATE | President and CEO | Sold | 43,947 | $2.46 | $108k | 591,815 | SEC |
| May 20, 2026 | May 21, 2026 | FATE | President and CEO | Sold | 28,946 | $1.88 | $54k | 635,762 | SEC |
| Jan 15, 2026 | Jan 16, 2026 | FATE | President and CEO | AwardedStock Option (Right to Buy) | 1.3M | 1.3M | SEC | ||
| Jan 15, 2026 | Jan 16, 2026 | FATE | President and CEO | Awarded | 335,000 | 664,708 | SEC | ||
| Jan 9, 2026 | Jan 12, 2026 | FATE | President and CEO | Sold | 5,190 | $1.07 | $6k | 329,708 | SEC |
| Aug 4, 2025 | Aug 5, 2025 | FATE | President and CEO | Sold | 14,466 | $1.06 | $15k | 334,898 | SEC |
| Jan 16, 2025 | Jan 16, 2025 | FATE | President and CEO | AwardedStock Option (Right to Buy) | 1.3M | 1.3M | SEC | ||
| Jan 10, 2025 | Jan 13, 2025 | FATE | President and CEO | Sold | 8,705 | $1.54 | $13k | 349,364 | SEC |
| Jul 29, 2024 | Jul 31, 2024 | FATE | Chief R&D Officer | Awarded | 200,000 | 358,069 | SEC | ||
| Feb 1, 2024 | Feb 2, 2024 | FATE | Chief R&D Officer | AwardedStock Option (Right to Buy) | 450,000 | 450,000 | SEC | ||
| Jan 9, 2024 | Jan 10, 2024 | FATE | Chief R&D Officer | Sold | 11,271 | $4.38 | $49k | 158,069 | SEC |
| Feb 6, 2023 | Feb 7, 2023 | FATE | Chief R&D Officer | AwardedStock Option (Right to Buy) | 450,000 | 450,000 | SEC | ||
| Jan 12, 2023 | Jan 13, 2023 | FATE | Chief R&D Officer | Exercised or settledStock Option (Right to Buy) | 423 | 0 | SEC | ||
| Jan 12, 2023 | Jan 13, 2023 | FATE | Chief R&D Officer | Exercised options | 423 | $1.37 | $580 | 169,340 | SEC |
| Jan 10, 2023 | Jan 11, 2023 | FATE | Chief R&D Officer | Sold | 10,917 | $5.24 | $57k | 168,917 | SEC |
| Jul 7, 2022 | Jul 8, 2022 | FATE | Chief R&D Officer | Sold | 17,158 | $30.23 | $519k | 179,834 | SEC |
| Jul 7, 2022 | Jul 8, 2022 | FATE | Chief R&D Officer | Exercised or settledStock Option (Right to Buy) | 17,158 | $2.73 | $47k | 13,156 | SEC |
| Jul 7, 2022 | Jul 8, 2022 | FATE | Chief R&D Officer | Exercised options | 17,158 | $2.73 | $47k | 196,992 | SEC |
| Jul 6, 2022 | Jul 7, 2022 | FATE | Chief R&D Officer | Sold | 7,842 | $30.07 | $236k | 179,834 | SEC |
| Jul 6, 2022 | Jul 7, 2022 | FATE | Chief R&D Officer | Exercised or settledStock Option (Right to Buy) | 7,842 | $3.27 | $26k | 30,314 | SEC |
| Jul 6, 2022 | Jul 7, 2022 | FATE | Chief R&D Officer | Exercised options | 7,842 | $3.27 | $26k | 187,676 | SEC |
| Mar 14, 2022 | Mar 15, 2022 | FATE | Chief R&D Officer | Sold | 25,000 | $31.07 | $777k | 179,834 | SEC |
| Mar 14, 2022 | Mar 15, 2022 | FATE | Chief R&D Officer | Exercised or settledStock Option (Right to Buy) | 25,000 | 36,156 | SEC | ||
| Mar 14, 2022 | Mar 15, 2022 | FATE | Chief R&D Officer | Exercised options | 25,000 | $2.73 | $68k | 204,834 | SEC |
| Jan 25, 2022 | Jan 27, 2022 | FATE | Officer | AwardedStock Option (Right to Buy) | 53,058 | 53,058 | SEC | ||
| Jan 25, 2022 | Jan 27, 2022 | FATE | Officer | Awarded | 33,302 | 179,834 | SEC | ||
| Jan 11, 2022 | Jan 13, 2022 | FATE | Chief R&D Officer | Sold | 4,570 | $48.50 | $222k | 146,532 | SEC |
| Jan 10, 2022 | Jan 12, 2022 | FATE | Chief R&D Officer | Sold | 5,596 | $46.38 | $260k | 151,102 | SEC |
| Dec 13, 2021 | Dec 14, 2021 | FATE | Chief R&D Officer | Sold | 25,000 | $47.66 | $1.2M | 156,698 | SEC |
| Dec 13, 2021 | Dec 14, 2021 | FATE | Chief R&D Officer | Exercised or settledStock Option (Right to Buy) | 25,000 | 61,156 | SEC | ||
| Dec 13, 2021 | Dec 14, 2021 | FATE | Chief R&D Officer | Exercised options | 25,000 | $2.73 | $68k | 181,698 | SEC |
| Nov 19, 2021 | Nov 22, 2021 | FATE | Chief R&D Officer | Awarded | 60,958 | 156,698 | SEC | ||
| Sep 13, 2021 | Sep 14, 2021 | FATE | Chief Development Officer | Sold | 25,000 | $66.29 | $1.7M | 95,740 | SEC |
| Sep 13, 2021 | Sep 14, 2021 | FATE | Chief Development Officer | Exercised or settledStock Option (Right to Buy) | 25,000 | 86,156 | SEC | ||
| Sep 13, 2021 | Sep 14, 2021 | FATE | Chief Development Officer | Exercised options | 25,000 | $2.73 | $68k | 120,740 | SEC |
| Jun 14, 2021 | Jun 16, 2021 | FATE | Chief Development Officer | Sold | 25,000 | $89.32 | $2.2M | 95,740 | SEC |
| Jun 14, 2021 | Jun 16, 2021 | FATE | Chief Development Officer | Exercised or settledStock Option (Right to Buy) | 25,000 | 111,156 | SEC | ||
| Jun 14, 2021 | Jun 16, 2021 | FATE | Chief Development Officer | Exercised options | 25,000 | $2.84 | $71k | 120,740 | SEC |
| Mar 15, 2021 | Mar 16, 2021 | FATE | Chief Development Officer | Sold | 25,000 | $92.35 | $2.3M | 95,740 | SEC |
| Mar 15, 2021 | Mar 16, 2021 | FATE | Chief Development Officer | Exercised or settledStock Option (Right to Buy) | 25,000 | 16,156 | SEC | ||
| Mar 15, 2021 | Mar 16, 2021 | FATE | Chief Development Officer | Exercised options | 25,000 | $2.90 | $73k | 120,740 | SEC |
| Jan 20, 2021 | Jan 22, 2021 | FATE | Chief Development Officer | AwardedStock Option (right to buy) | 6,851 | 6,851 | SEC | ||
| Jan 20, 2021 | Jan 22, 2021 | FATE | Chief Development Officer | Awarded | 18,013 | 95,740 | SEC | ||
| Jan 11, 2021 | Jan 12, 2021 | FATE | Chief Development Officer | Sold | 9,484 | $114.94 | $1.1M | 77,727 | SEC |
| Dec 14, 2020 | Dec 15, 2020 | FATE | Chief Development Officer | Sold | 25,000 | $97.78 | $2.4M | 87,211 | SEC |
| Dec 14, 2020 | Dec 15, 2020 | FATE | Chief Development Officer | Exercised or settledStock Option (right to buy) | 25,000 | 41,156 | SEC | ||
| Dec 14, 2020 | Dec 15, 2020 | FATE | Chief Development Officer | Exercised options | 25,000 | $2.90 | $73k | 112,211 | SEC |
| Sep 14, 2020 | Sep 16, 2020 | FATE | Chief Development Officer | Sold | 25,000 | $36.28 | $907k | 87,211 | SEC |
| Sep 14, 2020 | Sep 16, 2020 | FATE | Chief Development Officer | Exercised or settledStock Option (right to buy) | 25,000 | 66,156 | SEC | ||
| Sep 14, 2020 | Sep 16, 2020 | FATE | Chief Development Officer | Exercised options | 25,000 | $2.75 | $69k | 112,211 | SEC |
Page 1
Sales and notices (27)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Aug 5, 2026 | FATE | President and CEO | Form 4 sale | 43,947 | $108k | 6.9% | Unusual | SEC |
| Aug 4, 2026 | Aug 4, 2026 | FATE | President and CEO | Form 144 notice | 43,947 | $108k | Notice | SEC | |
| May 20, 2026 | May 21, 2026 | FATE | President and CEO | Form 4 sale | 28,946 | $54k | 4.4% | Unusual | SEC |
| May 20, 2026 | May 20, 2026 | FATE | President and CEO | Form 144 notice | 28,946 | $54k | Notice | SEC | |
| Jan 9, 2026 | Jan 12, 2026 | FATE | President and CEO | Form 4 sale | 5,190 | $6k | 1.5% | No plan | SEC |
| Jan 9, 2026 | Jan 9, 2026 | FATE | President and CEO | Form 144 notice | 5,190 | $6k | Notice | SEC | |
| Aug 4, 2025 | Aug 5, 2025 | FATE | President and CEO | Form 4 sale | 14,466 | $15k | 4.1% | No plan | SEC |
| Aug 4, 2025 | Aug 4, 2025 | FATE | President and CEO | Form 144 notice | 14,466 | $15k | Notice | SEC | |
| Jan 10, 2025 | Jan 13, 2025 | FATE | President and CEO | Form 4 sale | 8,705 | $13k | 2.4% | No plan | SEC |
| Jan 10, 2025 | Jan 10, 2025 | FATE | President and CEO | Form 144 notice | 8,705 | $13k | Notice | SEC | |
| Jan 9, 2024 | Jan 10, 2024 | FATE | Chief R&D Officer | Form 4 sale | 11,271 | $49k | 6.7% | No plan | SEC |
| Jan 9, 2024 | Jan 9, 2024 | FATE | President and CEO | Form 144 notice | 11,271 | $49k | Notice | SEC | |
| Jan 10, 2023 | Jan 11, 2023 | FATE | Chief R&D Officer | Form 4 sale | 10,917 | $57k | 6.1% | Plan not stated | SEC |
| Jul 7, 2022 | Jul 8, 2022 | FATE | Chief R&D Officer | Form 4 sale | 17,158 | $519k | 8.7% | Plan not stated | SEC |
| Jul 6, 2022 | Jul 7, 2022 | FATE | Chief R&D Officer | Form 4 sale | 7,842 | $236k | 4.2% | Plan not stated | SEC |
| Mar 14, 2022 | Mar 15, 2022 | FATE | Chief R&D Officer | Form 4 sale | 25,000 | $777k | 12.2% | Plan not stated | SEC |
| Jan 11, 2022 | Jan 13, 2022 | FATE | Chief R&D Officer | Form 4 sale | 4,570 | $222k | 3.0% | Plan not stated | SEC |
| Jan 10, 2022 | Jan 12, 2022 | FATE | Chief R&D Officer | Form 4 sale | 5,596 | $260k | 3.6% | Plan not stated | SEC |
| Dec 13, 2021 | Dec 14, 2021 | FATE | Chief R&D Officer | Form 4 sale | 25,000 | $1.2M | 13.8% | Plan not stated | SEC |
| Sep 13, 2021 | Sep 14, 2021 | FATE | Chief Development Officer | Form 4 sale | 25,000 | $1.7M | 20.7% | Plan not stated | SEC |
| Jun 14, 2021 | Jun 16, 2021 | FATE | Chief Development Officer | Form 4 sale | 25,000 | $2.2M | 20.7% | Plan not stated | SEC |
| Mar 15, 2021 | Mar 16, 2021 | FATE | Chief Development Officer | Form 4 sale | 25,000 | $2.3M | 20.7% | Plan not stated | SEC |
| Jan 11, 2021 | Jan 12, 2021 | FATE | Chief Development Officer | Form 4 sale | 9,484 | $1.1M | 10.9% | Plan not stated | SEC |
| Dec 14, 2020 | Dec 15, 2020 | FATE | Chief Development Officer | Form 4 sale | 25,000 | $2.4M | 22.3% | Unusual | SEC |
| Sep 14, 2020 | Sep 16, 2020 | FATE | Chief Development Officer | Form 4 sale | 25,000 | $907k | 22.3% | Plan not stated | SEC |
| Jan 8, 2020 | Jan 10, 2020 | FATE | Chief Development Officer | Form 4 sale | 5,700 | $118k | 6.2% | Plan not stated | SEC |
| Oct 15, 2019 | Oct 16, 2019 | FATE | Chief Development Officer | Form 4 sale | 6,200 | $88k | 8.5% | Plan not stated | SEC |